Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 83 results for "brian druker"

Beat AML initiative addresses the urgent need for a new approa...

Brian Druker, M.D., OHSU Knight Cancer Institute, discusses how the Author: LLS Oncology Tube, 1 month ago
Innovative Approach to Precision Trial Design: NCI-MATCH and Beat AML American Journal of Managed Care, 5 days ago

Treating cancer, mental health neglect in rural America

Jennifer Lycette, M.D., understands the importance of treating patients with cancer at home in their in rural communities. It allows them to spend more time with their families and to focus on their treatment and recovery, not traveling. Lycette ...
 EurekAlert!2 days ago
LLS Community

Teaming Up to Beat AML

This is the third in a series of blogs covering the 58th ASH Annual Meeting and Exposition (#ASH16) LLS's groundbreaking precision medicine clinical trial in acute myeloid leukemia (AML), has the potential to change the paradigm of AML and other ...
 LLS Community6 days ago #ASH16 (Blog 3): Teaming Up to Beat AML  Leukemia & Lymphoma Society3 days ago
LLS Community

#ASH16 (Blog 2): Innovations in AML and Surprising Results for CML

This is the second of a series of blogs covering the 58th ASH Annual Meeting and Exposition in San Diego (#ASH16) conference over the next few days. Check back for more news from the meeting. On the first official day of the 58th ASH Annual ...
 LLS Community3 days ago #ASH16 Day 1: Innovations in AML and Surprising Results for CML  LLS Community1 week ago
EurekAlert!

Study: Enhancing cancer response to radiation

IMAGE: Researchers Cristina Espinosa, Rebecca Ruhl and Sudarshan Anand in the lab. view more OHSU researcher Sudarshan Anand, Ph.D., has a contemporary analogy to describe microRNA: "I sometimes compare MicroRNA to tweets -- they're short, ...
 EurekAlert!1 week ago

GRAIL Announces Circulating Cell-free Genome Atlas (CCGA) Study as Foundation for Development of Blood Test to Detect Cancer Early

- GRAIL to Apply High-Intensity Sequencing on an Unprecedented Scale to Build an Atlas of Cancer Biology - - Initial Collaborators Include Guardian Research Network, Mayo Clinic and Hartford HealthCare Cancer Institute - MENLO PARK, Calif., Dec.
 4 Traders1 week ago
[x]  

Blueprint Medicines Received its Third Buy in a Row

After Cowen & Co. and Wedbush assigned a Buy rating to Blueprint Medicines in the last month, the company received another Buy, this time from Canaccord Genuity. Analyst Arlinda Lee reiterated a Buy rating on Blueprint Medicines (NASDAQ: BPMC ) ...
 Analyst Ratings.com1 week ago

American Society of Hematology's 2016 Inside Look: Insights from Program Chairs, Speakers, Moderators, and more

This year's ASH Annual Meeting and Exposition , taking place December 3-6 in San Diego, California, features a diverse lineup of educational activities, networking opportunities, and practice-changing science. ASH Clinical News spoke with the ...
 ASH Clinical News2 weeks ago
US Daily Review

Groundbreaking Treatment for Deadly BloodCancer

ByUSDR Going on the offensive against one of the most daunting challenges in cancer, The Leukemia & Lymphoma Society (LLS) today announced the launch of a groundbreaking, collaborative clinical trial for acute myeloid leukemia (AML), a deadly ...
 US Daily Review3 weeks ago LLS launches collaborative clinical trial for acute myeloid leukemia  Pharmaceutical Business Review1 month ago The Leukemia & Lymphoma Society Launches Groundbreaking Precision Medicine Approach to Treat Acute Myeloid Leukemia, One of the Deadliest Blood Cancers  BioSpace1 month ago LLS Launches Groundbreaking Precision Medicine Approach to Treat AML  Leukemia & Lymphoma Society1 month ago
[x]  
PRWeb

NanoString Technologies Teams with the OHSU Knight Cancer Institute to Develop Myeloid Gene Expression Panels to Advance Immuno-Oncology Research

In Special Recognition of the work of The Stand Up To Cancer-Lustgarten Foundation Pancreatic Dream Team and in honor of Pancreatic Cancer Awareness Month SEATTLE, Nov. 10, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. ( NASDAQ:NSTG ), a ...
 BioSpace1 month ago NANOSTRING TECHNOLOGIES : UPDATE NanoString Technologies Teams with the OHSU Knight Cancer Institute to Develop Myeloid Gene Expression Panels to Advance Immuno-Oncology Research  4 Traders4 weeks ago UPDATE NanoString Technologies Teams with the OHSU Knight Cancer Institute to Develop Myeloid Gene Expression Panels to Advance Immuno-Oncology Research  Financial Buzz4 weeks ago NANOSTRING TECHNOLOGIES : Teams with the OHSU Knight Cancer Institute to Develop Myeloid Gene Expression Panels to Advance Immuno-Oncology Research  4 Traders4 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less